Notably, in human colorectal cancer cell lines, the EGFR-induced tyrosine phosphorylation of PPARδ led to the recruitment of HSP90, and its stabilization conferred chemoresistance to the EGFR inhibitor gefitinib [17]. This evidence concerns the gene EGFR and colorectal cancer.